[HONG KONG, May 8, 2021] Chairman of Great Bay Bio Limited, Mr. Kingsley Leung, was invited to participate in the "Youth Novation Start-up Cmpetition" hosted by Hong Kong Youth Development Alliance. Hong Kong Youth Development Alliance (YDAHK) is committ

[HONG KONG, April 29, 2021] Hong Kong Science and Technology Parks Corporation (HKSTP) and Federation of Hong Kong Industries (FHKI) today launched the joint R&D Hub programme to give visionary leaders and businesses from Hong Kong’s manufacturing industr

[Hong Kong, March 31, 2021] Great Bay Bio Holdings Limited (hereinafter referred to as “GBB”) is pleased to announce that the company’s self-developed AI-enabled cell culture media development platform, AlfaMedX®, is officially launched. AlfaMedX is crea

[Hong Kong, February 23, 2021] Great Bay Bio Holdings Limited (hereinafter referred to as "GBB") today announced it has completed a USD$3.8M Convertible Note Financing. Alibaba Hong Kong Entrepreneurs Fund (hereinafter referred to as "AEF") led the invest

[Hong Kong, January 22, 2021]Recently, theGreat Bay Bio Family celebrated the past year’s achievement in a special way.

[香港，2020年12月24日] 近日，大湾生物再次获评高新技术企业。 高新技术企业属于国家级荣誉，是指在《国家重点支持的高新技术领域》内持续进行研究开发与技术成果转化，形成企业核心自主知识产权，并以此为基

[香港，2020年12月23日] 近日，历时近半年的第三届粤港澳大湾区生物科技创新企业50强评选活动圆满结束，大湾生物荣膺粤港澳大湾区生物科技创新企业50强，并获得“先锋企业”称号。 本次活动由中创产业研究

[香港，2020年11月13日] 近日，一年一度的YIAH＆IOY颁奖典礼暨晚宴如期举行，专注于以人工智能开发生物医药的大湾生物董事长梁国龙先生被授予“香港青年工业家奖”称号。 香港青年工业家奖（“YIAH